DB-Biotech
Monospecific Clonal Antibodies
Founded in 2006, DB Biotech has earned an international reputation for the development of high quality antibodies used in research and routine clinical diagnostics. DB Biotech is focused on the design and production of high quality rabbit clonal antibodies developed by a novel and proprietary in-vitro cloning technology which has been developed and perfected by the DBB scientific team over a period of 20 years. DB Biotech monospecific clonal antibodies are uniquely characterized by exceptional specificity, affinity and avidity.
The DB Biotech in-vitro cloning technology enables the preparation of a pure immunoglobulin fraction corresponding to a single clone of B lymphocytes. The obtained immunoglobulin recognizes only one single linear epitope on the antigen molecule, making a DB Biotech antibody comparable in quality to its monoclonal analogue. DB Biotech produced antibodies correspond strictly to the conserved linear epitope of the antigen molecule, yielding a higher-quality, more specific antibody with significantly better affinity and avidity.
Product Range:
- Antibodies for IHC-P
- Antibodies for Western Blot, ELISA, IP and ICC
- Antibodies for flow cytometry
- Detection system
- RT-PCR Kit for COVID-19
- TMA Building Kit
Fluorochem
Biochemicals, Bioactive Small Molecules, and Building Blocks
Dojindo
Reagents and kits for life science research
Abitec
Larodan Research Grade Lipids
Virax Biolabs
Innovating Immunology Research
Biogenex
Molecular pathology systems